DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us | Job opportunities

News


Search news :

UKPDS Outcomes Model software 1.0 released

01-Dec-2004
News Image

[Link]

Paper on aspirin use in Type 2 diabetes published in Diabetic Medicine

01-Dec-2004
News Image Changing aspirin use in patients with Type 2 diabetes in the UKPDS
Cull CA, Neil HA, Holman RR
Diabetic Medicine 2004; 21:1368-71

AIMS: To examine the proportion of UK Prospective Diabetes Study (UKPDS) patients with Type 2 diabetes taking aspirin regularly for the primary and secondary prevention of cardiovascular disease (CVD) before and after publication of the 1997 American Diabetes Association (ADA) Clinical Practice Recommendations and the 1998 Joint British Recommendations on the Prevention of Coronary Disease in Clinical Practice. METHODS: UKPDS annual review data from 1996/7 (n = 3190) and 2000/1 (n = 2467) were used to determine the prevalence of patients taking aspirin regularly in relation to known CVD risk factors and pre-existing CVD....

[Read more...]

GADA prevalence in type 2 diabetes (ADOPT)

01-Dec-2004
News Image Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe
Zinman B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI; ADOPT Study Group
Diabetes 2004;53:3193-3200

[Link]

UKPDS paper 69 published in Archives of Ophthalmology

01-Nov-2004
News Image Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.

Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM; UK Prospective Diabetes Study Group....

[Read more...]

AFORRD Study commences recruitment

01-Nov-2004
News Image The Atorvastatin in Factorial with Omega-3 fatty acids Risk Reduction in Diabetes (AFORRD) study began recruiting participants on Monday 1st November 2004. AFORRD is assessing the degree to which a statin and/or omega-3 fatty acids are likely to reduce coronary heart disease (CHD) risk in people with Type 2 diabetes....

[Read more...]

4-T Study commences recruitment

01-Nov-2004
News Image The Treating To Target in Type 2 Diabetes (4-T) study began recruiting participants on Monday 1st November 2004.

UKPDS paper 68 published in Diabetologia

01-Oct-2004
News Image A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS 68)
P. M....

[Read more...]

DREAM protocol paper published in Diabetologia

01-Sep-2004
News Image Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial
Gerstein HC, Yusuf S, Holman RR, Bosch J, Pogue J; The DREAM Trial Investigators
Diabetologia 2004;47:1519-1527

AIMS/HYPOTHESIS: Diabetes is a rapidly rising independent risk factor for atherosclerosis and serious illness. This risk can be reduced by lifestyle changes and/or various drugs....

[Read more...]

HOMA Calculator 2.2 released

30-Jun-2004
News Image The HOMA Calculator has been updated to provide HOMA2 IR values automatically, in addition to HOMA2 %S and HOMA2 %B. Fixes a problem running the HOMA Calculator on Windows 98.

[Link]

HOMA Calculator released

01-Jun-2004
News Image The HOMA Calculator provides quick and easy access to the HOMA model for researchers who wish to use model-derived estimates of beta cell function ( %B), insulin sensitivity (%S) or insulin resistance (HOMA IR), rather than linear approximations. It runs on a variety of computer platforms and can be downloaded from this site

[Link]

UKPDS Risk Engine 2.0 released

26-Feb-2004
News Image Version 2.0 of the UKPDS Risk Engine provides separate risk estimates and 95% confidence intervals for fatal coronary heart disease and for fatal stroke. Printing for MacOS and Windows has been improved and support has been added for PocketPC machines.

[Link]

OTTT paper published in Diabetes Care

01-Jan-2004
News Image A Standardized Triglyceride and Carbohydrate Challenge.
Nina Mohanlal, Rury Holman
Diabetes Care (2004) 27: 89-94

OBJECTIVE— A standardized method of assessing postprandial triglyceride changes is not available....

[Read more...]

The AFORRD study

01-Jan-2004
News Image The Atorvastatin in Factorial with Omega-3 fatty acids Risk Reduction in Diabetes (AFORRD) study is assessing the degree to which a statin and/or omega-3 fatty acids are likely to reduce coronary heart disease (CHD) risk in people with Type 2 diabetes. This 1000 patient, one-year study is being conducted by the Diabetes Trials Unit in an academic collaboration with Pfizer UK.

[Link]

UKPDS paper 66 published in Diabetes Care

01-Jan-2004
News Image Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes.
Richard J....

[Read more...]